Date	Period	Revenue/Estimate	Earnings Call
--	2025/H2	-- / 61.200M	--
--	2025/H1	-- / 35.300M	--
Aug 29, 2024	2024/H2	55.921M / 55.100M	--
Feb 22, 2024	2024/H1	32.257M / 34.433M	--
Aug 29, 2023	2023/H2	48.966M / 46.300M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/H2-- / 61.200M--

--2025/H1-- / 35.300M--

Aug 29, 20242024/H255.921M / 55.100M--

Feb 22, 20242024/H132.257M / 34.433M--

Aug 29, 20232023/H248.966M / 46.300M--

Unlock Free Earnings Estimates

Open Account

Clinuvel Pharmaceuticals Ltd: Investor Presentation

Aug 28 19:32 ET

Clinuvel Pharmaceuticals Ltd: CLINUVEL delivers increases in annual revenue, profit

Aug 28 19:32 ET

Clinuvel Pharmaceuticals Ltd: Appendix 4E and Annual Report to Shareholders 2024

Aug 28 19:22 ET

Clinuvel Pharmaceuticals Ltd: CLINUVEL Delivers Increased Revenues, Solid Earnings

Feb 21 18:11 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Oct 25, 2024

Strong Buy

No Data